Victory Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,879
Closed -$90.2K 2593
2023
Q4
$90.2K Sell
13,879
-15,755
-53% -$102K ﹤0.01% 2359
2023
Q3
$280K Buy
29,634
+3,235
+12% +$38.9K ﹤0.01% 2137
2023
Q2
$369K Buy
26,399
+168
+0.6% +$2.86K ﹤0.01% 2062
2023
Q1
$492K Sell
26,231
-15,233
-37% -$250K ﹤0.01% 2011
2022
Q4
$571K Buy
41,464
+20,359
+96% +$312K ﹤0.01% 1965
2022
Q3
$404K Sell
21,105
-9,154
-30% -$167K ﹤0.01% 2146
2022
Q2
$462K Sell
30,259
-10,202
-25% -$151K ﹤0.01% 2089
2022
Q1
$545K Buy
40,461
+8,447
+26% +$172K ﹤0.01% 2097
2021
Q4
$934K Sell
32,014
-1,614
-5% -$46.2K ﹤0.01% 1875
2021
Q3
$725K Buy
33,628
+14,389
+75% +$347K ﹤0.01% 1993
2021
Q2
$493K Buy
+19,239
New +$411K ﹤0.01% 2214
2020
Q3
Sell
-28,900
Closed -$190K 2570
2020
Q2
$190K Buy
28,900
+11,920
+70% +$66.5K ﹤0.01% 2307
2020
Q1
$86K Buy
+16,980
New +$103K ﹤0.01% 2590
2019
Q4
Sell
-8,885
Closed -$47K 3354
2019
Q3
$47K Buy
+8,885
New +$55.2K ﹤0.01% 2719

Other funds holding CDMO

Victory Capital Management's CDMO Position: Q1 2024 in Review

Victory Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 13,879 shares — an estimated $90.2K sold.

Victory Capital Management first reported a position in CDMO in Q3 2019 and held it in 14 quarters. The position peaked at $934K in Q4 2021. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Victory Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 13,879 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $90.2K.
  • Victory Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 14 quarters.
  • Victory Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $934K in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.